Compugen Ltd (CGEN)
1.41
-0.04
(-2.76%)
USD |
NASDAQ |
Nov 22, 16:00
1.44
+0.03
(+2.13%)
Pre-Market: 08:36
Compugen Net Income (Annual): -18.75M for Dec. 31, 2023
Net Income (Annual) Chart
Historical Net Income (Annual) Data
Date | Value |
---|---|
December 31, 2023 | -18.75M |
December 31, 2022 | -33.69M |
December 31, 2021 | -34.20M |
December 31, 2020 | -29.70M |
December 31, 2019 | -27.34M |
December 31, 2018 | -22.60M |
December 31, 2017 | -37.07M |
December 31, 2016 | -31.51M |
December 31, 2015 | -20.16M |
December 31, 2014 | -11.09M |
December 31, 2013 | -14.08M |
December 31, 2012 | -13.63M |
December 31, 2011 | -12.00M |
Date | Value |
---|---|
December 31, 2010 | -7.203M |
December 31, 2009 | -3.831M |
December 31, 2008 | -12.53M |
December 31, 2007 | -12.11M |
December 31, 2006 | -13.02M |
December 31, 2005 | -13.98M |
December 31, 2004 | -13.72M |
December 31, 2003 | -11.44M |
December 31, 2002 | -12.20M |
December 31, 2001 | -15.14M |
December 31, 2000 | -13.40M |
December 31, 1999 | -8.129M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Annual) Range, Past 5 Years
-34.20M
Minimum
2021
-18.75M
Maximum
2023
-28.74M
Average
-29.70M
Median
2020
Net Income (Annual) Benchmarks
Pluri Inc | -20.89M |
BioLine Rx Ltd | -60.61M |
XTL Biopharmaceuticals Ltd | -1.782M |
Can Fite Biofarma Ltd | -7.634M |
BiomX Inc | -26.17M |